HomeCompareIDCBY vs MRK

IDCBY vs MRK: Dividend Comparison 2026

IDCBY yields 3.69% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IDCBY wins by $63.2K in total portfolio value
10 years
IDCBY
IDCBY
● Live price
3.69%
Share price
$17.58
Annual div
$0.65
5Y div CAGR
39.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.9K
Annual income
$40,838.99
Full IDCBY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — IDCBY vs MRK

📍 IDCBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIDCBYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IDCBY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IDCBY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IDCBY
Annual income on $10K today (after 15% tax)
$313.79/yr
After 10yr DRIP, annual income (after tax)
$34,713.14/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, IDCBY beats the other by $26,384.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IDCBY + MRK for your $10,000?

IDCBY: 50%MRK: 50%
100% MRK50/50100% IDCBY
Portfolio after 10yr
$88.4K
Annual income
$25,318.57/yr
Blended yield
28.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IDCBY
No analyst data
Altman Z
0.1
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IDCBY buys
0
MRK buys
0
No recent congressional trades found for IDCBY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIDCBYMRK
Forward yield3.69%2.76%
Annual dividend / share$0.65$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR39.3%32.7%
Portfolio after 10y$119.9K$56.8K
Annual income after 10y$40,838.99$9,798.13
Total dividends collected$90.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IDCBY vs MRK ($10,000, DRIP)

YearIDCBY PortfolioIDCBY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,214$514.25$11,206$366.19+$8.00IDCBY
2$12,750$750.78$12,650$502.35+$100.00IDCBY
3$14,754$1,111.28$14,407$694.19+$347.00IDCBY
4$17,461$1,674.11$16,585$967.82+$876.00IDCBY
5$21,262$2,579.33$19,342$1,363.89+$1.9KIDCBY
6$26,840$4,089.06$22,913$1,947.19+$3.9KIDCBY
7$35,438$6,719.83$27,662$2,823.89+$7.8KIDCBY
8$49,470$11,551.04$34,159$4,173.35+$15.3KIDCBY
9$73,925$20,992.19$43,337$6,308.80+$30.6KIDCBY
10$119,939$40,838.99$56,776$9,798.13+$63.2KIDCBY

IDCBY vs MRK: Complete Analysis 2026

IDCBYStock

Industrial and Commercial Bank of China Limited, together with its subsidiaries, provides banking products and services in the People's Republic of China and internationally. It operates through Corporate Banking, Personal Banking, and Treasury Operations segments. The Corporate Banking segment offers financial products and services to corporations, government agencies, and financial institutions. Its products and services include corporate loans, trade financing, deposit taking activities, corporate wealth management services, custody activities, and various corporate intermediary services. The Personal Banking segment provides financial products and services to individual customers. This segment's products and services comprise personal loans and cards, deposits, and personal wealth management and intermediary services. The Treasury Operations segment is involved in the money market transactions, investment securities, and foreign exchange transactions businesses, as well as in the holding of derivative positions. It also offers e-banking services, investment banking, financial leasing, and insurance services. The company was founded in 1984 and is based in Beijing, the People's Republic of China.

Full IDCBY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IDCBY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IDCBY vs SCHDIDCBY vs JEPIIDCBY vs OIDCBY vs KOIDCBY vs MAINIDCBY vs JNJIDCBY vs ABBVIDCBY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.